Modelos pronósticos para la cirrosis hepática by Luis Calzadilla Bertot, Eduardo Vilar Gómez, Laritza Lincheta Enriquez

Get full text

Enfermedad hepática por depósitos grasos. Una perspectiva actual by Luis Alberto Pérez Blanco, Eduardo Vilar Gómez, Yadina Martínez Pérez, Luis Calzadilla Bertot

Get full text

Tratamiento prolongado con interferón alfa-2b más lamivudina en pacientes con hepatitis crónica B y antígeno e positivo Prolonged treatment with alpha-2b interferon plus lamivudine... by Eduardo Vilar Gómez, Bienvenido Grá Orama, Enrique Arús Soler, Caridad Ruenes Domech, Yudith Dávila González

Get full text

Arterial blood pressure is closely related to ascites development in compensated HCV-related cirrhosis. by Eduardo Vilar Gomez, Ana Torres Gonzalez, Luis Calzadilla Bertot, Ali Yasells Garcia, Yoan Sanchez Rodriguez, Yadina Martinez Perez

Get full text

MASLD in persons with HIV is associated with high cardiometabolic risk as evidenced by altered advanced lipoprotein profiles and targeted metabolomics by Kung-Hung Lin, Eduardo Vilar-Gomez, Kathleen E. Corey, Margery A. Connelly, Samir K. Gupta, Jordan E. Lake, Naga Chalasani, Samer Gawrieh

Get full text

Extra-hepatic comorbidity burden significantly increases 90-day mortality in patients with cirrhosis and high model for endstage liver disease by Scott Coppel, Karan Mathur, Burcin Ekser, Kavish R. Patidar, Eric Orman, Archita P. Desai, Eduardo Vilar-Gomez, Chandrashekhar Kubal, Naga Chalasani, Lauren Nephew, Marwan Ghabril

Get full text

Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial by Samer Gawrieh, Laura A. Wilson, Katherine P. Yates, Oscar W. Cummings, Eduardo Vilar‐Gomez, Veeral Ajmera, Kris V. Kowdley, William M. Rosenberg, James Tonascia, Naga Chalasani

Get full text